CUBE vs IONS · P/E 25, rev $1.07B vs rev $226.6M
CubeSmart (CUBE) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the CUBE and IONS stock pages for the full models.
Not investment advice.